Close Menu

NEW YORK — Cytek Biosciences said on Tuesday that its portfolio of seven Class I IVD flow cytometry reagents has received approval from the China National Medical Products Administration (NMPA).

According to the Fremont, California-based company, the reagents consist of basic T, B, and NK cell cluster of differentiation markers used for lymphocyte subset detection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.